| CRISPR Medicine | This is an overview of articles on delivery
Sign-up to weekly Newsletter here.
AAV trailblazer Nicole Paulk, formerly of UCSF, speaks about the latest developments in AAV-based gene therapies and her new company, Siren...
In a recent study, researchers in Denmark engineered lentiviruses to incorporate Cas9 protein fused to viral proteins to allow packaging of Cas9 into...
Webinar
Read more about the webinar - A Novel Non-viral Cargo Delivery Platform: The First in a New Class
Irish-Indian company CyGenica is on a mission to solve the huge challenge surrounding targeted intracellular delivery of gene-editing and other...
At a length of around 100 nucleotides, single guide RNAs are not synthesised efficiently. However, thanks to click chemistry, they can now be...
Extended survival times and inhibited growth of patient-derived glioblastoma brain tumours have been achieved in mice with CRISPR-Cas9 mediated...
A CRISPR-based therapy for the metabolic liver disease phenylketonuria (PKU) has moved one step forward. In vivo prime editing in neonate mice...
Most pharmaceuticals don't reach the brain, leaving cognitive impairments due to diseases like mucopolysaccharidoses (MPS) hard to treat. Now, a...